ID: ALA2381015

Max Phase: Preclinical

Molecular Formula: C19H23ClN2O3

Molecular Weight: 362.86

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC1CCC(N2C(=O)CC(=O)N(CCc3cccc(Cl)c3)C2=O)C1

Standard InChI:  InChI=1S/C19H23ClN2O3/c1-2-13-6-7-16(11-13)22-18(24)12-17(23)21(19(22)25)9-8-14-4-3-5-15(20)10-14/h3-5,10,13,16H,2,6-9,11-12H2,1H3

Standard InChI Key:  ASUPALFNMIVBLS-UHFFFAOYSA-N

Associated Targets(non-human)

CACNA1C Voltage-gated L-type calcium channel alpha-1C subunit (335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cacna1d Voltage-gated L-type calcium channel alpha-1D subunit (336 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 362.86Molecular Weight (Monoisotopic): 362.1397AlogP: 3.64#Rotatable Bonds: 5
Polar Surface Area: 57.69Molecular Species: ACIDHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 5.00CX Basic pKa: CX LogP: 3.88CX LogD: 1.55
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.75Np Likeness Score: -0.76

References

1. Kang S, Cooper G, Dunne SF, Luan CH, Surmeier DJ, Silverman RB..  (2013)  Structure-activity relationship of N,N'-disubstituted pyrimidinetriones as Ca(V)1.3 calcium channel-selective antagonists for Parkinson's disease.,  56  (11): [PMID:23651412] [10.1021/jm4005048]

Source